+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hemagglutination-inhibiting antibody responses in human infections with group B coxsackieviruses



Hemagglutination-inhibiting antibody responses in human infections with group B coxsackieviruses



Journal of Immunology 96(2): 311-318



Hemagglutination-inhibiting (HI) antibody responses for coxsackievirus types B1, B3 and B5 were compared with neutralizing antibody responses with respect to sensitivity, specificity and diagnostic value in patients with and without coxsackievirus infections. Most sera possessed nonspecific inhibitors for hemagglutinins of these viral types, but treatment of sera with filtrates from a psychrophylic Pseudomonas sp. was found to be highly effective for removing such inhibitors; this treatment appeared to have little or not detrimental effect on specific antibody. HI tests on treated sera were comparable to neutralization tests in diagnostic value, with 46% of patients with isolations of coxsackievirus types Bl, B3 and B5 showing significant rises in homotypic antibody titers by both tests. Heterotypic antibody rises seen in HI tests on treated sera corresponded with those observed in neutralization tests. HI antibody was rarely observed in treated sera in the absence of neutralizing antibody for the corresponding viral type.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 024774266

Download citation: RISBibTeXText

PMID: 5933646


Related references

Neutralizing, hemagglutination-inhibiting and group complement-fixing antibody responses in human adenovirus infections. Journal of Immunology 97(1): 64-74, 1966

Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience. American Journal of Tropical Medicine and Hygiene 15(4): 601-610, 1966

Antibody Responses of Rhesus (Macaca Mulatta) Monkeys Experimentally Infected with Coxsackieviruses of Group B and Group A, Type 9. I. Antibody Responses with the Coxsackievirus Group. Journal of Immunology 95: 54-69, 1965

Antibody responses of rhesus (Macaca mulatta) monkeys experimentally infected with coxsackieviruses of group B and group A, type 9. II. Heterotypic antibody responses to echoviruses, polioviruses and reovirus type 1. Journal of Immunology 98(5): 1060-1066, 1967

Antibody responses of rhesus monkeys experimentally infected with coxsackieviruses of group B and group A, type 9 II Heterotypic antibody responses to echovlruses, pollovlruses and reo-virus type 1. J Immunol: 1060-1066, 1967

Hemagglutination-inhibition antibody responses in human adenovirus infections. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 108: 474-479, 1961

Hemagglutination-inhibiting, complement-fixing and neutralizing antibody responses in ECHO 6 infection, including studies on heterotypic responses. Journal of Immunology 88: 47-54, 1962

Identification of group A coxsackieviruses by immune adherence hemagglutination. Japanese Journal of Medical Science and Biology 36(4): 199-207, 1983

Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine. Journal of Virological Methods 182(1-2): 43-49, 2012

Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. Journal of Virology 56(2): 651-654, 1985

A nonneutralizing human IgM monoclonal antibody inhibiting hemagglutination of H3N2 influenza A strains. Hybridoma 5(4): 307-318, 1986

Comparison of the hemagglutination-inhibiting and neutralizing antibody responses of volunteers given 400 chick cell-agglutinating units of influenza A/New Jersey/76 split-virus vaccine. Journal of Infectious Diseases 136 Suppl: S472-S474, 1977

Gel double diffusion studies with group B and group A, type 9, coxsackieviruses. III. Antigen-antibody absorption tests. J Immunol 94(4): 482-497, 1965

Gel Double Diffusion Studies with Group B and Group A, Type 9, Coxsackieviruses. 3. Antigen-Antibody Absorption Tests. Journal of Immunology 94: 482-491, 1965

Study of coxsackievirus group A. II. Neutralization antibody positive against coxsackieviruses group A of sera of children in Gifu Prefecture. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 72(1): 36-39, 1998